Global University Venturing

Epidarex Capital has launched a new drug discovery initiative providing seed funding and hands-on support to nurture fledgling projects.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Building on translational science from Stanford, Jasper has secured funding to progress its Amgen-licensed conditioning agent for patients awaiting stem cell transplants.

The number of acquisitions of companies that have received corporate backing had been decreasing over the past few years but by the end of October this year it registered a rebound.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The cancer drug developer emerged from stealth with $194m in funding, $85m of which was just closed in a round featuring returning investor Roche Venture Fund.

Carnegie Mellon University's language teaching app Duolingo has received series F funding from existing backer CapitalG and is now valued at $1.5bn.

Gene therapy developer Limelight Bio grew from research at University of Pennsylvania and has landed $75m in its first publicly-disclosed round.

Mac Ventures will receive support from Yeshiva University business school students, making early-stage investments in a number of tech-oriented sectors.

Rogue Venture Partners-backed Streem has been bought by Frontdoor, which has plans for its augmented reality-based remote home services technology.

Pfizer Ventures led the immuno-oncology drug developer's latest round, which was spun out of Institut Paoli-Calmettes with the help of Satt Sud-Est and Inserm Transfert.